Skip to main content
. 2020 Feb 5;11(2):164. doi: 10.3390/genes11020164

Figure 3.

Figure 3

Relative fold changes of miR-133b and miR-21 in different categories of CAD compared to healthy controls. MiR-133b was downregulated by 8.45 fold in ACS, 3.38 fold in SA and 2.08 fold in NCA category patients as compared to healthy subjects. MiR-21 was upregulated by 2.46 fold in ACS, 1.90 fold in SA and 1.12 fold in NCA category patients as compared to healthy subjects.